• Exchange: Berlin
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

XBX:GR

17.158 EUR 0.106 0.61%

As of 09:34:22 ET on 09/18/2014.

Snapshot for Cambrex Corp (XBX)

Open: 17.065 Day's Range: 17.065 - 17.158 Volume: 0
Previous Close: 17.264 52wk Range: 9.422 - 17.600 1-Yr Rtn: +79.78%

Stock Chart for XBX

No chart data available.
  • XBX:GR 17.158
  • 1D
  • 1M
  • 1Y
17.264
Interactive XBX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for XBX

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 20.6648
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) 1.0730
Est. PEG Ratio 1.4252
Market Cap (M EUR) 526.41
Shares Outstanding (M) 30.68
30 Day Average Volume 19
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend (USD) 14.0000
Dividend Ex-Date 05/04/2007
5 Year Dividend Growth -
Next Earnings Announcement 10/31/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for XBX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for XBX

Cambrex Corp. supplies products, services, and technologies for the Life Sciences and fine chemicals industry. The Company builds platforms for use in manufacturing small molecule Active Pharmaceutical Ingredients (APIs) and pharmaceutical intermediates including drug delivery. Cambrex's services include process & analytical development, scale-up in addition to generic APIs.

Steven M Klosk "Steve"President/CEOGregory P SargenExec VP/CFO
Shawn P CavanaghExec VP/COOWilliam M HaskelSenior VP/Secretary/Gen Cnsl
More Company Profile & Key Executives for XBX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil